Combination therapy more effective in treating patients with leishmaniasis and HIV

(Drugs for Neglected Diseases Initiative) The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières (MSF), the University of Gondar, and Addis Ababa University, open the way for more effective and safer treatments for people with both HIV and visceral leishmaniasis (VL), a group of patients who have historically suffered from poor treatment options. The results were published today in PLOS Neglected Tropical Diseases.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2Ct2EYd